Gen-Probe Incorporated
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 30, 2003

Gen-Probe Incorporated

(Exact Name of Registrant as Specified in Charter)
         
Delaware
(State or Other Jurisdiction of
Incorporation)
  0-49834
(Commission
File Number)
  33-0044608
(I.R.S. Employer
Identification No.)

10210 Genetic Center Drive
San Diego, CA 92121

(Address of Principal Executive Offices)


(858) 410-8000
(Registrant’s telephone number, including area code)


 


TABLE OF CONTENTS

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
Item 12. Results of Operations and Financial Condition.
SIGNATURE
EXHIBITS
EXHIBIT 99.1


Table of Contents

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.

(c)   The following exhibits are furnished with this Current Report:
     
99.1   News release dated October 30, 2003

Item 12. Results of Operations and Financial Condition.

     On October 30, 2003, Gen-Probe Incorporated issued a news release announcing its financial results for the fiscal quarter ended September 30, 2003. A copy of this news release is attached hereto as Exhibit 99.1.

     In accordance with General Instruction B-6 of Form 8-K, the information furnished pursuant to this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or under the Securities Exchange Act of 1934, as amended, unless Gen-Probe expressly sets forth in such filing that such information is to be considered “filed” or incorporated by reference therein.

 


Table of Contents

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
Date: October 30, 2003   GEN-PROBE INCORPORATED
         
    By:   /s/ R. William Bowen
       
        R. William Bowen
        Vice President, General Counsel and
        Corporate Secretary

 


Table of Contents

EXHIBITS

     
Exhibit    
Number   Description

 
99.1   News Release dated October 30, 2003